Neuroimaging Spectrum of Erdheim-Chester Disease: An Image-Based Review

References

1. 1.↵
   1. Matzumura M,
   2. Arias-Stella J,
   3. Novak JE

   . Erdheim-Chester disease: a rare presentation of a rare disease. J Investig Med High Impact Case Rep 2016;4:2324709616663233 doi:10.1177/2324709616663233 pmid:27606325

   CrossRefPubMed
2. 2.↵
   1. Emile JF,
   2. Abla O,
   3. Fraitag S

   ; Histiocyte Society, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016;127:2672–81 doi:10.1182/blood-2016-01-690636 pmid:26966089

   Abstract/FREE Full Text
3. 3.↵
   1. Cohen Aubart F,
   2. Idbaih A,
   3. Galanaud D, et al

   . Central nervous system involvement in Erdheim-Chester disease: an observational cohort study. Neurology 2020;95:e2746–54 doi:10.1212/WNL.0000000000010748 pmid:32887776

   CrossRefPubMed
4. 4.↵
   1. Zahergivar A,
   2. Firouzabadi FD,
   3. Homayounieh F, et al

   . Central nervous system involvement in Erdheim-Chester disease: a magnetic resonance imaging study. Clin Imaging 2024;115:110281 doi:10.1016/j.clinimag.2024.110281 pmid:39270429

   CrossRefPubMed
5. 5.↵
   1. Vaidya T,
   2. Mahajan A,
   3. Rane S

   . Multimodality imaging manifestations of Rosai-Dorfman disease. Acta Radiology Open 2020;9:2058460120946719 doi:10.1177/2058460120946719 pmid:32884838

   CrossRefPubMed
6. 6.↵
   1. Grois N,
   2. Fahrner B,
   3. Arceci RJ

   ; Histiocyte Society CNS LCH Study Group, et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr 2010;156:873–81 doi:10.1016/j.jpeds.2010.03.001 pmid:20434166

   CrossRefPubMed
7. 7.↵
   Histiocytosis Association. Erdheim-Chester disease. November 12, 2020. Accessed August 25, 2024. https://histio.org/histiocytic-disorders/erdheim-chester-disease/
8. 8.↵
   1. Haque A,
   2. Pérez CA,
   3. Reddy TA, et al

   . Erdheim–Chester disease with isolated CNS involvement: a systematic review of the literature. Neurol Int 2022;14:716–26 doi:10.3390/neurolint14030060 pmid:36135995

   CrossRefPubMed
9. 9.↵
   1. Haroche J,
   2. Cohen-Aubart F,
   3. Amoura Z

   . Erdheim-Chester disease. Blood 2020;135:1311–18 doi:10.1182/blood.2019002766 pmid:32107533

   CrossRefPubMed
10. 10.↵
    1. Drier A,
    2. Haroche J,
    3. Savatovsky J, et al

    . Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 2010;255:586–94 doi:10.1148/radiol.10090320 pmid:20413768

    CrossRefPubMed
11. 11.↵
    1. Garg N,
    2. Lavi ES

    . Clinical and neuroimaging manifestations of Erdheim-Chester Disease: a review. J Neuroimaging 2021;31:35–44 doi:10.1111/jon.12785 pmid:32920940

    CrossRefPubMed
12. 12.↵
    1. Toya T,
    2. Ogura M,
    3. Toyama K, et al

    . Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan. Haematologica 2018;103:1815–24 doi:10.3324/haematol.2018.190728 pmid:29976744

    Abstract/FREE Full Text
13. 13.↵
    1. Diamond EL,
    2. Durham BH,
    3. Haroche J, et al

    . Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 2016;6:154–65 doi:10.1158/2159-8290.CD-15-0913 pmid:26566875

    Abstract/FREE Full Text
14. 14.↵
    1. Fasulo S,
    2. Alkomos MF,
    3. Pjetergjoka R, et al

    . Erdheim-Chester disease presenting at the central nervous system. Autops Case Rep 2021;11:e2021321 doi:10.4322/acr.2021.321 pmid:34540726

    CrossRefPubMed
15. 15.↵
    1. Sedrak P,
    2. Ketonen L,
    3. Hou P, et al

    . Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease. AJNR Am J Neuroradiol 2011;32:2126–31 doi:10.3174/ajnr.A2707 pmid:21960492

    Abstract/FREE Full Text
16. 16.↵
    1. Fernández-Eulate G,
    2. Muñoz-Lopetegi A,
    3. Ruiz I, et al

    . Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement. BMJ Case Rep 2019;12:e228280 doi:10.1136/bcr-2018-228280

    CrossRefPubMed
17. 17.↵
    1. Diamond EL,
    2. Durham BH,
    3. Ulaner GA, et al

    . Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature 2019;567:521–2 doi:10.1038/s41586-019-1012-y pmid:30867592

    CrossRefPubMed
18. 18.↵
    1. Estrada-Veras JI,
    2. O’Brien KJ,
    3. Boyd LC, et al

    . The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv 2017;1:357–66 doi:10.1182/bloodadvances.2016001784 pmid:28553668

    Abstract/FREE Full Text
19. 19.↵
    1. Ambrosini V,
    2. Savelli F,
    3. Merli E, et al

    . F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease. Clin Nucl Med 2012;37:196–97 doi:10.1097/RLU.0b013e31823e9d54 pmid:22228352

    CrossRefPubMed
20. 20.↵
    1. Boyd LC,
    2. O’Brien KJ,
    3. Ozkaya N, et al

    . Neurological manifestations of Erdheim–Chester disease. Ann Clin Transl Neurol 2020;7:497–506 doi:10.1002/acn3.51014 pmid:32227455

    CrossRefPubMed
21. 21.↵
    1. Goyal G,
    2. Heaney ML,
    3. Collin M, et al

    . Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 2020;135:1929–45 doi:10.1182/blood.2019003507 pmid:32187362

    CrossRefPubMed
22. 22.↵
    1. Bhatia A,
    2. Hatzoglou V,
    3. Ulaner G, et al

    . Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series. Neuro Oncol 2020;22:979–92 doi:10.1093/neuonc/noaa008 pmid:31950179

    CrossRefPubMed
23. 23.↵
    1. Cives M,
    2. Simone V,
    3. Rizzo FM, et al

    . Erdheim–Chester disease: a systematic review. Crit Rev Oncol Hematol 2015;95:1–11 doi:10.1016/j.critrevonc.2015.02.004 pmid:25744785

    CrossRefPubMed
24. 24.↵
    1. Arnaud L,
    2. Hervier B,
    3. Néel A, et al

    . CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011;117:2778–82 doi:10.1182/blood-2010-06-294108 pmid:21239701

    Abstract/FREE Full Text
25. 25.↵
    1. Papo M,
    2. Diamond EL,
    3. Cohen-Aubart F, et al

    . High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. Blood 2017;130:1007–13 doi:10.1182/blood-2017-01-761718 pmid:28679734

    Abstract/FREE Full Text
26. 26.↵
    1. Fan X,
    2. Liu T,
    3. Zhang Z, et al

    . Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients. Eur Radiology 2023;33:8031–42 doi:10.1007/s00330-023-09724-8 pmid:37191919

    CrossRefPubMed
27. 27.↵
    1. Perry VH

    . Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol)2010;120:277–86 doi:10.1007/s00401-010-0722-x pmid:20644946

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Diamond EL,
    2. Hatzoglou V,
    3. Patel S, et al

    . Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease. Orphanet J Rare Dis 2016;11:109 doi:10.1186/s13023-016-0490-3 pmid:27484739

    CrossRefPubMed
29. 29.↵
    1. Kumar P,
    2. Singh A,
    3. Gamanagatti S, et al

    . Imaging findings in Erdheim-Chester disease: what every radiologist needs to know. Pol J Radiology 2018;83:e54–62 doi:10.5114/pjr.2018.73290 pmid:30038679

    CrossRefPubMed
30. 30.↵
    1. Parks NE,
    2. Goyal G,
    3. Go RS, et al

    . Neuroradiologic manifestations of Erdheim-Chester disease. Neurol Clin Pract 2018;8:15–20 doi:10.1212/CPJ.0000000000000422 pmid:29517068

    Abstract/FREE Full Text
31. 31.↵
    1. Wang F,
    2. Cao X,
    3. Niu N, et al

    . Multisystemic imaging findings in Chinese patients with Erdheim-Chester disease. AJR Am J Roentgenol 2019;213:1179–86 doi:10.2214/AJR.19.21523 pmid:31532257

    CrossRefPubMed
32. 32.↵
    1. Rangankar V,
    2. Ajmera P,
    3. Agarwal N, et al

    . Erdheim–Chester disease: with neurological manifestation and multisystem involvement: case report and radiological review. Egypt J Radiol Nucl Med 2021;52:261 doi:10.1186/s43055-021-00641-8

    CrossRef
33. 33.↵
    1. Wang Y,
    2. Camelo-Piragua S,
    3. Abdullah A, et al

    . Neuroimaging features of CNS histiocytosis syndromes. Clin Imaging 2020;60:131–40 doi:10.1016/j.clinimag.2019.10.001 pmid:31874337

    CrossRefPubMed
34. 34.↵
    1. Benson JC,
    2. Vaubel R,
    3. Ebne BA, et al

    . Erdheim-Chester disease. AJNR Am J Neuroradiol 2023;44:505–10 doi:10.3174/ajnr.A7832 pmid:36997288

    Abstract/FREE Full Text
35. 35.↵
    1. Mazor RD,
    2. Manevich-Mazor M,
    3. Kesler A, et al

    . Clinical considerations and key issues in the management of patients with Erdheim-Chester disease: a seven case series. BMC Med 2014;12:221 doi:10.1186/s12916-014-0221-3 pmid:25434739

    CrossRefPubMed
36. 36.↵
    1. Jeon I,
    2. Choi JH

    . Isolated thoracic intramedullary Erdheim-Chester disease presenting with paraplegia: a case report and literature review. BMC Musculoskelet Disord 2021;22:270 doi:10.1186/s12891-021-04061-7 pmid:33711983

    CrossRefPubMed
37. 37.↵
    1. Tien RD,
    2. Brasch RC,
    3. Jackson DE, et al

    . Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images. Radiology 1989;172:791–92 doi:10.1148/radiology.172.3.2772189 pmid:2772189

    CrossRefPubMed
38. 38.↵
    1. Babu RP,
    2. Lansen TA,
    3. Chadburn A, et al

    . Erdheim-Chester disease of the central nervous system: report of two cases. J Neurosurg 1997;86:888–92 doi:10.3171/jns.1997.86.5.0888 pmid:9126908

    CrossRefPubMed
39. 39.↵
    1. Adem C,
    2. Hélie O,
    3. Lévêque C, et al

    . Case 78: Erdheim-Chester disease with central nervous system involvement. Radiology 2005;234:111–15 doi:10.1148/radiol.2341021806 pmid:15618378

    CrossRefPubMed
40. 40.↵
    1. Aswani Y,
    2. Patel A,
    3. Zhan X, et al

    . Imaging in Erdheim-Chester disease. RadioGraphics 2024;44:e240011 doi:10.1148/rg.240011 pmid:39172709

    CrossRefPubMed
41. 41.↵
    1. Conley A,
    2. Manjila S,
    3. Guan H, et al

    . Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease. Neuropathology 2010;30:634–47 doi:10.1111/j.1440-1789.2010.01104.x pmid:20337948

    CrossRefPubMed
42. 42.↵
    1. Suzuki H,
    2. Wanibuchi M,
    3. Komatsu K, et al

    . Erdheim-Chester disease involving the central nervous system with the unique appearance of a coated vertebral artery. NMC Case Rep J 2016;3:125–28 doi:10.2176/nmccrj.cr.2015-0331 pmid:28664013

    CrossRefPubMed
43. 43.↵
    1. Takeuchi T,
    2. Sato M,
    3. Sonomura T, et al

    . Erdheim-Chester disease associated with intramedullary spinal cord lesion. Br J Radiology 2012;85:e62–64 doi:10.1259/bjr/65720693 pmid:22391503

    Abstract/FREE Full Text
44. 44.↵
    1. Viswanathan S,
    2. Kadir NA,
    3. Lip AC, et al

    . Central nervous system Erdheim Chester disease presenting with raised intracranial pressure and cerebellar signs mimicking neurosarcoidosis with secondary cerebral venous thrombosis. Neurol India 2014;62:446–48 doi:10.4103/0028-3886.141250 pmid:25237960

    CrossRefPubMed
45. 45.↵
    1. Weon YC,
    2. Kim EY,
    3. Kim HJ, et al

    . Intracranial solitary fibrous tumors: imaging findings in 6 consecutive patients. AJNR Am J Neuroradiol 2007;28:1466–69 doi:10.3174/ajnr.A0609 pmid:17846192

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Noh SM,
    2. Kang HG

    . Embolic infarction with subdural hemorrhage in Erdheim-Chester disease. J Clin Neurol 2020;16:349–51 doi:10.3988/jcn.2020.16.2.349 pmid:32319260

    CrossRefPubMed
47. 47.↵
    1. Pan Z,
    2. Kleinschmidt-DeMasters BK

    . CNS Erdheim–Chester disease: a challenge to diagnose. J Neuropathol Exp Neurol 2017;76:986–96 doi:10.1093/jnen/nlx095 pmid:29096034

    CrossRefPubMed
48. 48.↵
    1. Huang Z,
    2. Li S,
    3. Hong J, et al

    . Erdheim–Chester disease mimicking lumbar nerve schwannoma: case report and literature review. Spinal Cord Ser Cases 2019;5:90 doi:10.1038/s41394-019-0234-4 pmid:31700688

    CrossRefPubMed
49. 49.↵
    1. Polk C,
    2. Weida C,
    3. Patel N, et al

    . Erdheim-Chester disease presenting as meningitis with hypoglycorrhachia: A case report. Medicine (Baltimore) 2022;101:e30585 doi:10.1097/MD.0000000000030585 pmid:36123925

    CrossRefPubMed
50. 50.↵
    1. Globerman H,
    2. Burstein S,
    3. Girardina PJ, et al

    . A xanthogranulomatous histiocytosis in a child presenting with short stature. Am J Pediatr Hematol Oncol 1991;13:42–46 doi:10.1097/00043426-199121000-00010 pmid:1903027

    CrossRefPubMed
51. 51.↵
    1. Caparros-Lefebvre D,
    2. Pruvo JP,
    3. Rémy M, et al

    . Neuroradiologic aspects of Chester-Erdheim disease. AJNR Am J Neuroradiol 1995;16:735–40pmid:7611030

    Abstract/FREE Full Text
52. 52.↵
    1. De Abreu MR,
    2. Chung CB,
    3. Biswal S, et al

    . Erdheim-Chester disease: MR imaging, anatomic, and histopathologic correlation of orbital involvement. AJNR Am J Neuroradiol 2004;25:627–30 pmid:15090356

    PubMed
53. 53.↵
    1. Haroche J,
    2. Gueniche Y,
    3. Galanaud D, et al

    . Erdheim-Chester disease: look it in the eye. An orbital magnetic resonance imaging study. Haematologica 2022;107:2667–74 doi:10.3324/haematol.2021.280510 pmid:35484665

    CrossRefPubMed
54. 54.↵
    1. Abdellatief A,
    2. Mason CM,
    3. Ytterberg SR, et al

    . Choroidal involvement in Erdheim-Chester disease. Ophthalmic Surg Lasers Imaging Retina 2015;46:674–76 doi:10.3928/23258160-20150610-13 pmid:26114850

    CrossRefPubMed
55. 55.↵
    1. Wang JN,
    2. Qiu Y,
    3. Niu N, et al

    . Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy. Acta Oncol 2020;59:302–05 doi:10.1080/0284186X.2019.1670355 pmid:31559889

    CrossRefPubMed
56. 56.↵
    1. Grazzini I,
    2. Venezia D,
    3. Del Roscio D, et al

    . Morphological and functional neuroradiology of brain metastases. Semin Ultrasound CT MR 2023;44:170–93 doi:10.1053/j.sult.2023.03.004 pmid:37245883

    CrossRefPubMed
57. 57.↵
    1. Bönig L,
    2. Möhn N,
    3. Ahlbrecht J, et al

    . Leptomeningeal metastasis: the role of cerebrospinal fluid diagnostics. Front Neurol 2019;10:839 doi:10.3389/fneur.2019.00839 pmid:31481919

    CrossRefPubMed
58. 58.↵
    1. Bathla G,
    2. Hegde A

    . Lymphomatous involvement of the central nervous system. Clin Radiology 2016;71:602–09 doi:10.1016/j.crad.2016.02.006 pmid:27038652

    CrossRefPubMed
59. 59.↵
    1. Bathla G,
    2. Abdel-Wahed L,
    3. Agarwal A, et al

    . Vascular involvement in neurosarcoidosis: early experiences from intracranial vessel wall imaging. Neurol Neuroimmunol Neuroinflammation 2021;8:e1063 doi:10.1212/NXI.0000000000001063

    Abstract/FREE Full Text
60. 60.↵
    1. Bathla G,
    2. Singh AK,
    3. Policeni B, et al

    . Imaging of neurosarcoidosis: common, uncommon, and rare. Clin Radiol 2016;71:96–106 doi:10.1016/j.crad.2015.09.007 pmid:26506463

    CrossRefPubMed
61. 61.↵
    1. Soni N,
    2. Bathla G,
    3. Pillenahalli Maheshwarappa R

    . Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature. Neuroradiol J 2019;32:17–28 doi:10.1177/1971400918806634 pmid:30311851

    CrossRefPubMed
62. 62.↵
    1. Berkman J,
    2. Ford C,
    3. Johnson E, et al

    . Misdiagnosis: CNS Erdheim-Chester disease mimicking CLIPPERS. Neuroradiol J 2018;31:399–402 doi:10.1177/1971400917710251 pmid:28685649

    CrossRefPubMed
63. 63.↵
    1. Guzman-Soto MI,
    2. Kimura Y,
    3. Romero-Sanchez G, et al

    . From head to toe: granulomatosis with polyangiitis. Radiographics 2021;41:1973–91 doi:10.1148/rg.2021210132 pmid:34652975

    CrossRefPubMed
64. 64.↵
    1. Huynh KN,
    2. Kong MJ,
    3. Nguyen BD

    . Anatomic and functional imaging of immunoglobulin G4–related disease and its mimics. RadioGraphics 2023;43:e220097 doi:10.1148/rg.220097 pmid:36821510

    CrossRefPubMed
65. 65.↵
    1. Baptista B,
    2. Casian A,
    3. Gunawardena H, et al

    . Neurological manifestations of IgG4-related disease. Curr Treat Options Neurol 2017;19:14 doi:10.1007/s11940-017-0450-9 pmid:28374231

    CrossRefPubMed